FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520299947> ?p ?o ?g. }

• W1520299947 endingPage "4466" @default.
• W1520299947 startingPage "4458" @default.
• W1520299947 abstract "We have used a transient transfection system with a cytomegalovirus-based vector expressing high levels of biologically active human estrogen receptor (ER) in COS-1 cells to study the phosphorylation of human ER and to identify major hormone-regulated phosphorylation sites. The features of phosphorylation of the wild-type ER were very similar to those previously observed for the endogenous ER in uterine cells: The ER exhibited a basal level of phosphorylation which was increased approximately 3-4-fold by estrogen (estradiol) and by antiestrogens (hydroxytamoxifen and ICI164,384), and phosphorylation was increased to an almost similar extent by activation of either protein kinase A or C signal transduction pathways with cholera toxin plus isobutyl methylxanthine (CT+IBMX) or phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA), respectively. Phosphoamino acid analysis revealed that the phosphorylation occurred exclusively on serine residues in all cases. Tryptic phosphopeptide analysis of ER, using a two-dimensional peptide mapping procedure, revealed similar patterns for ER in cells treated with estradiol, antiestrogens or TPA; with CT+IBMX treatment, the same phosphopeptides were seen, but the relative phosphorylation of the different ER phosphotryptic peptides differed. In ER deleted of the NH2-terminal A and B (A/B) domains, estrogen and antiestrogen-stimulated phosphorylations were abolished, while the phosphorylation induced by CT+IBMX was maintained. This suggests that sites of phosphorylation enhanced by estradiol and antiestrogen, but not those induced by CT+IBMX, are located in the A/B domain. These results were further confirmed by comparing the tryptic phosphopeptide patterns of wild-type and A/B-deleted receptor upon estradiol and CT+IBMX treatments, and then by site-directed mutagenesis, by substituting alanines for the serine residues in the A/B domain (Ser104, Ser106, Ser118, Ser154, and Ser167) involved in known protein kinase consensus sequences. Comparison of the tryptic phosphopeptide patterns of wild-type ER and these mutant ERs allowed us to identify serine 104 and/or serine 106 and serine 118, all three being part of a serine-proline motif, the preferred substrate of proline-directed protein kinase, as major ER phosphorylation sites. When tested with two estrogen-responsive reporter gene constructs in several cell types, the mutant S104A, S106A, S118A showed a approximately 40% reduction in transactivation activity in response to E2, while the mutants S118A and S104A, S106A alone showed a approximately 15% decrease in transactivation. Our studies identify several serines in the NH2-terminal portion of the human ER as being major hormone-regulated phosphorylation sites.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
• W1520299947 created "2016-06-24" @default.
• W1520299947 creator A5026569515 @default.
• W1520299947 creator A5029943599 @default.
• W1520299947 creator A5036829000 @default.
• W1520299947 creator A5080531304 @default.
• W1520299947 date "1994-02-01" @default.
• W1520299947 modified "2023-10-11" @default.
• W1520299947 title "Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity." @default.
• W1520299947 cites W1492607760 @default.
• W1520299947 cites W1494025494 @default.
• W1520299947 cites W1513409211 @default.
• W1520299947 cites W1514833389 @default.
• W1520299947 cites W1516538526 @default.
• W1520299947 cites W1527997452 @default.
• W1520299947 cites W1528493806 @default.
• W1520299947 cites W1558227941 @default.
• W1520299947 cites W1565210265 @default.
• W1520299947 cites W1567716082 @default.
• W1520299947 cites W1582868418 @default.
• W1520299947 cites W1594758412 @default.
• W1520299947 cites W1850214287 @default.
• W1520299947 cites W1971960644 @default.
• W1520299947 cites W1979801990 @default.
• W1520299947 cites W1982925298 @default.
• W1520299947 cites W1985780256 @default.
• W1520299947 cites W1985860736 @default.
• W1520299947 cites W2000719556 @default.
• W1520299947 cites W2003347015 @default.
• W1520299947 cites W2012945894 @default.
• W1520299947 cites W2042976701 @default.
• W1520299947 cites W2044469448 @default.
• W1520299947 cites W2053944784 @default.
• W1520299947 cites W2058354524 @default.
• W1520299947 cites W2063404851 @default.
• W1520299947 cites W2066441904 @default.
• W1520299947 cites W2085124463 @default.
• W1520299947 cites W2085905389 @default.
• W1520299947 cites W2099558657 @default.
• W1520299947 cites W2125013861 @default.
• W1520299947 cites W2135564507 @default.
• W1520299947 cites W2149137184 @default.
• W1520299947 cites W2160583719 @default.
• W1520299947 cites W2343796556 @default.
• W1520299947 cites W320849627 @default.
• W1520299947 cites W979725628 @default.
• W1520299947 doi "https://doi.org/10.1016/s0021-9258(17)41801-1" @default.
• W1520299947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8308015" @default.
• W1520299947 hasPublicationYear "1994" @default.
• W1520299947 type Work @default.
• W1520299947 sameAs 1520299947 @default.
• W1520299947 citedByCount "408" @default.
• W1520299947 countsByYear W15202999472012 @default.
• W1520299947 countsByYear W15202999472013 @default.
• W1520299947 countsByYear W15202999472014 @default.
• W1520299947 countsByYear W15202999472015 @default.
• W1520299947 countsByYear W15202999472016 @default.
• W1520299947 countsByYear W15202999472017 @default.
• W1520299947 countsByYear W15202999472018 @default.
• W1520299947 countsByYear W15202999472019 @default.
• W1520299947 countsByYear W15202999472020 @default.
• W1520299947 countsByYear W15202999472021 @default.
• W1520299947 countsByYear W15202999472022 @default.
• W1520299947 countsByYear W15202999472023 @default.
• W1520299947 crossrefType "journal-article" @default.
• W1520299947 hasAuthorship W1520299947A5026569515 @default.
• W1520299947 hasAuthorship W1520299947A5029943599 @default.
• W1520299947 hasAuthorship W1520299947A5036829000 @default.
• W1520299947 hasAuthorship W1520299947A5080531304 @default.
• W1520299947 hasBestOaLocation W15202999471 @default.
• W1520299947 hasConcept C116834253 @default.
• W1520299947 hasConcept C11960822 @default.
• W1520299947 hasConcept C121608353 @default.
• W1520299947 hasConcept C134018914 @default.
• W1520299947 hasConcept C170493617 @default.
• W1520299947 hasConcept C185592680 @default.
• W1520299947 hasConcept C18903297 @default.
• W1520299947 hasConcept C2777164284 @default.
• W1520299947 hasConcept C530470458 @default.
• W1520299947 hasConcept C54355233 @default.
• W1520299947 hasConcept C55493867 @default.
• W1520299947 hasConcept C71315377 @default.
• W1520299947 hasConcept C84606932 @default.
• W1520299947 hasConcept C86803240 @default.
• W1520299947 hasConcept C95444343 @default.
• W1520299947 hasConceptScore W1520299947C116834253 @default.
• W1520299947 hasConceptScore W1520299947C11960822 @default.
• W1520299947 hasConceptScore W1520299947C121608353 @default.
• W1520299947 hasConceptScore W1520299947C134018914 @default.
• W1520299947 hasConceptScore W1520299947C170493617 @default.
• W1520299947 hasConceptScore W1520299947C185592680 @default.
• W1520299947 hasConceptScore W1520299947C18903297 @default.
• W1520299947 hasConceptScore W1520299947C2777164284 @default.
• W1520299947 hasConceptScore W1520299947C530470458 @default.
• W1520299947 hasConceptScore W1520299947C54355233 @default.
• W1520299947 hasConceptScore W1520299947C55493867 @default.
• W1520299947 hasConceptScore W1520299947C71315377 @default.
• W1520299947 hasConceptScore W1520299947C84606932 @default.

• next